Showing results (11-20 of 318) with videos related to

Sort By:
Pageof 32
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|August 11, 2005
Myocardial insulin resistance and cardiac complications of diabetesE Dale Abel
Experimental Biology and Medicine (Maywood, N.J.)|December 4, 2010
Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean miceJason M Tanner, Devin T Kearns, Bum Jun Kim, et al.
Hypertension (Dallas, Tex. : 1979)|November 4, 2009
Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive ratsWill Soesanto, Han-Yi Lin, Eric Hu, et al.
Cardiovascular Research|January 25, 2011
Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophyE Dale Abel, Torsten Doenst
Physiology (Bethesda, Md.)|July 27, 2006
Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetesSihem Boudina, E Dale Abel
Diabetologia|January 31, 2014
Molecular mechanisms of diabetic cardiomyopathyHeiko Bugger, E Dale Abel
Clinical Science (London, England : 1979)|January 11, 2008
Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndromeHeiko Bugger, E Dale Abel
Circulation|June 27, 2007
Diabetic cardiomyopathy revisitedSihem Boudina, E Dale Abel
Cardiovascular Research|July 20, 2010
Mitochondria in the diabetic heartHeiko Bugger, E Dale Abel
Biochimie|April 12, 2012
Modulation of the cardiovascular system by leptinE Dale Abel, Gary Sweeney
Pageof 32